Snapshot

The JFDA Abridged Procedure pathway has been developed by the Jordan Food and Drug Administration (JFDA) of Jordan.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

When relevant, the agency relies on prior decisions from EU-EMA United States

90-day review procedure conditional on approval issued either by either EMA or FDA as main eligibility criteria.